Johnson & Johnson: Stroke trials
The registry lists 14 Stroke studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 1Phase 3 5No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Post Marketing Study to Evaluate the NIMBUS DeviceCompletedNCT03898960Results posted
- WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2TerminatedNCT03302494Phase 3Results posted
- WAVECREST Post Market Clinical Follow-Up (PMCF) StudyTerminatedNCT03204695Not applicableResults posted
- Analysis of Revascularization in Ischemic Stroke With EmboTrapCompletedNCT02488915Not applicableResults posted
- Analysis of Revascularisation in Ischemic Stroke With EmboTrapTerminatedNCT02190552Results posted
- A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsCompletedNCT02111564Phase 3Results posted
- Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)CompletedNCT01895634Not applicableResults posted
- A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureCompletedNCT01877915Phase 3Results posted
- An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationCompletedNCT00403767Phase 3Results posted
- A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age GroupCompletedNCT04002700
- CERENOVUS Neurothrombectomy Devices RegistryCompletedNCT03685578
- A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and ImplicationsCompletedNCT02830178
- A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)CompletedNCT01273467Phase 1
- A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)TerminatedNCT00073372Phase 3